| Product Code: ETC7542106 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Duchenne Muscular Dystrophy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Duchenne Muscular Dystrophy Market Revenues & Volume, 2021 & 2031F |
3.3 India Duchenne Muscular Dystrophy Market - Industry Life Cycle |
3.4 India Duchenne Muscular Dystrophy Market - Porter's Five Forces |
3.5 India Duchenne Muscular Dystrophy Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 India Duchenne Muscular Dystrophy Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 India Duchenne Muscular Dystrophy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Duchenne Muscular Dystrophy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 India Duchenne Muscular Dystrophy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Duchenne Muscular Dystrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Duchenne Muscular Dystrophy (DMD) in India |
4.2.2 Advancements in medical research and technology for DMD treatment |
4.2.3 Rising healthcare expenditure and government initiatives for rare disease management |
4.3 Market Restraints |
4.3.1 High costs associated with DMD treatment and therapies |
4.3.2 Limited availability of specialized healthcare professionals for DMD |
4.3.3 Challenges in early diagnosis and access to appropriate care for DMD patients |
5 India Duchenne Muscular Dystrophy Market Trends |
6 India Duchenne Muscular Dystrophy Market, By Types |
6.1 India Duchenne Muscular Dystrophy Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Mutation Suppression, 2021- 2031F |
6.1.4 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Exon Skipping Approach, 2021- 2031F |
6.2 India Duchenne Muscular Dystrophy Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Molecular-based Therapies, 2021- 2031F |
6.2.3 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Steroid Therapy, 2021- 2031F |
6.2.4 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Duchenne Muscular Dystrophy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Duchenne Muscular Dystrophy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Duchenne Muscular Dystrophy Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 India Duchenne Muscular Dystrophy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Duchenne Muscular Dystrophy Market Import-Export Trade Statistics |
7.1 India Duchenne Muscular Dystrophy Market Export to Major Countries |
7.2 India Duchenne Muscular Dystrophy Market Imports from Major Countries |
8 India Duchenne Muscular Dystrophy Market Key Performance Indicators |
8.1 Average age of diagnosis for DMD patients in India |
8.2 Number of clinical trials and research studies focused on DMD in India |
8.3 Percentage of DMD patients receiving timely access to specialized care and treatment |
8.4 Rate of adoption of new DMD therapies and interventions |
8.5 Patient satisfaction and quality of life improvements measured through patient-reported outcomes |
9 India Duchenne Muscular Dystrophy Market - Opportunity Assessment |
9.1 India Duchenne Muscular Dystrophy Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 India Duchenne Muscular Dystrophy Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 India Duchenne Muscular Dystrophy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Duchenne Muscular Dystrophy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 India Duchenne Muscular Dystrophy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Duchenne Muscular Dystrophy Market - Competitive Landscape |
10.1 India Duchenne Muscular Dystrophy Market Revenue Share, By Companies, 2024 |
10.2 India Duchenne Muscular Dystrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here